Qiagen (NYSE:QGEN – Get Free Report) was upgraded by equities researchers at UBS Group to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks reports. Other equities research analysts also recently issued reports about the stock. Berenberg Bank set a $45.50 target price on shares of Qiagen and gave […]